# Create research centers where participants remain free to choose

Proposed civilian clinical research · No recruitment before approvals. Start the Philippine cannabis program with a clinical lead, an academic host, and an independent feasibility review of one medical question. Seek a complementary US collaborator with relevant scientific experience. Build the study around a justified participant population and outcome, rather than around a supply of easily monitored people. Begin with evidence and product assessment before proposing human exposure.

Canonical page: https://givegigs.com/wiki/necro-chapter-cannabis-civilian-centers
Last updated: 2026-11-09T18:58:12.584Z
Parent topic: [necromancer-cannabis](https://givegigs.com/wiki/necromancer-cannabis)

## Contents
- [Overview](#wiki-section-overview-1)
- [Chapter notes](#wiki-section-chapter-notes-2)
- [Dossier section](#wiki-section-dossier-link-3)

<a id="wiki-section-overview-1"></a>
## Overview

Proposed civilian clinical research · No recruitment before approvals. This page expands the “Create research centers where participants remain free to choose” chapter in the cannabis collection.

<a id="wiki-section-chapter-notes-2"></a>
## Chapter notes

Start the Philippine cannabis program with a clinical lead, an academic host, and an independent feasibility review of one medical question. Seek a complementary US collaborator with relevant scientific experience. Build the study around a justified participant population and outcome, rather than around a supply of easily monitored people. Begin with evidence and product assessment before proposing human exposure.

A qualified team should design an appropriate comparison, prespecified outcomes, analysis plan, and safety oversight. Diet, sleep, medication, prior exposure, and relevant medical history can be measured with consent and addressed in study design. Randomization and suitable controls help evaluate differences; neither a laboratory nor continuous observation makes human participants identical.

Provide understandable consent materials in participants' languages, time for questions, a real right to withdraw, proportionate compensation, privacy protections, and arrangements for research-related injury. Register studies where required and publish results with limitations. Philippine ethics review and US institutional review board requirements must be resolved for the activities and institutions actually involved.

<a id="wiki-section-dossier-link-3"></a>
## Dossier section

[Open this exact section in the Necromancer dossier](/necromancer#cannabis-civilian-centers). The original chapter status is “Proposed civilian clinical research · No recruitment before approvals.”

## Sources

- [2022 National Ethical Guidelines for Research Involving Human Participants](https://www.fatima.edu.ph/wp-content/uploads/2024/11/National-Ethical-Guideliens-for-Research-Involving-Human-Participants.pdf)
- [AO 2020-0010: Regulations on the Conduct of Clinical Trials](https://www.fda.gov.ph/administrative-order-no-2020-0010-regulations-on-the-conduct-of-clinical-trials-for-investigational-products/)
- [FDA and Cannabis: Research and Drug Approval Process](https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process)

---
This article is collaboratively maintained. Check the canonical page and cited sources for the latest context.